- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
A near-manic focus on efficiency and moves into new products mean that more growth is coming.
These stocks have started to climb on bad news, but the optimists should be wary.
Psychologist Brett Steenbarger offers tips for trading in these range-bound times.
As the stain of scandals past lingers, stocks with good governance track records have been rewarded by investors.
Dividend-payers stand to thrive with the former; discount retailers would do well with the latter.
Humans are conditioned to interpret data in a way that supports existing views. That's dangerous for traders.
Companies that help people rebuild from Charley's devastation should show big profits.
As buyout activity picks up, Macerich and Mills Corp. look compelling.
Reconstruction after the powerful storm could bolster select regional banks.
The troubled company has earned its detractors, but Tuesday's selloff could have gone too far.